ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	10/39	95/10704	9.6067792473083e-13	2.21916600612822e-10	1.45618548590778e-10	PABPC1/RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	10
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	10/39	111/10704	4.7091443766858e-12	3.66894040303018e-10	2.40750703138002e-10	PABPC1/RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	10
R-HSA-927802	Nonsense-Mediated Decay (NMD)	10/39	115/10704	6.74317799051499e-12	3.66894040303018e-10	2.40750703138002e-10	PABPC1/RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	10
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	10/39	115/10704	6.74317799051499e-12	3.66894040303018e-10	2.40750703138002e-10	PABPC1/RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	10
R-HSA-72613	Eukaryotic Translation Initiation	10/39	119/10704	9.52971533254591e-12	3.66894040303018e-10	2.40750703138002e-10	PABPC1/RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	10
R-HSA-72737	Cap-dependent Translation Initiation	10/39	119/10704	9.52971533254591e-12	3.66894040303018e-10	2.40750703138002e-10	PABPC1/RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	10
R-HSA-156902	Peptide chain elongation	9/39	89/10704	2.17092768131241e-11	6.26855367978959e-10	4.11333665932878e-10	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-192823	Viral mRNA Translation	9/39	89/10704	2.17092768131241e-11	6.26855367978959e-10	4.11333665932878e-10	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-156842	Eukaryotic Translation Elongation	9/39	93/10704	3.25185723663125e-11	6.82890019692563e-10	4.4810281538268e-10	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-2408557	Selenocysteine synthesis	9/39	93/10704	3.25185723663125e-11	6.82890019692563e-10	4.4810281538268e-10	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-72764	Eukaryotic Translation Termination	9/39	93/10704	3.25185723663125e-11	6.82890019692563e-10	4.4810281538268e-10	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-72689	Formation of a pool of free 40S subunits	9/39	101/10704	6.91830613566163e-11	1.22932978256757e-09	8.0666889355083e-10	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-9633012	Response of EIF2AK4 (GCN2) to amino acid deficiency	9/39	101/10704	6.91830613566163e-11	1.22932978256757e-09	8.0666889355083e-10	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	9/39	112/10704	1.77007271581065e-10	2.7259119823484e-09	1.7887050601876e-09	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	9/39	112/10704	1.77007271581065e-10	2.7259119823484e-09	1.7887050601876e-09	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-2408522	Selenoamino acid metabolism	9/39	118/10704	2.83666339348554e-10	4.09543277434475e-09	2.6873653201442e-09	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-9010553	Regulation of expression of SLITs and ROBOs	10/39	171/10704	3.54534090059572e-10	4.81749263551535e-09	3.1611708339677e-09	PABPC1/RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	10
R-HSA-168273	Influenza Viral RNA Transcription and Replication	9/39	135/10704	9.49637969505442e-10	1.21870206086532e-08	7.99695132215109e-09	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-168255	Influenza Infection	9/39	156/10704	3.43293656284603e-09	4.17372813693386e-08	2.73874163462509e-08	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-376176	Signaling by ROBO receptors	10/39	218/10704	3.79107838722532e-09	4.37869553724525e-08	2.87323835663393e-08	PABPC1/RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	10
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	9/39	184/10704	1.46439945788812e-08	1.61083940367693e-07	1.05701013501699e-07	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-8868773	rRNA processing in the nucleus and cytosol	9/39	194/10704	2.32239977649256e-08	2.43851976531719e-07	1.60012233404272e-07	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-72312	rRNA processing	9/39	204/10704	3.59219331950964e-08	3.60781155133359e-07	2.36739513963107e-07	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-72649	Translation initiation complex formation	6/39	58/10704	5.51560132232144e-08	5.30876627273439e-07	3.48353767725565e-07	PABPC1/RPS12/RPS17/RPS18/RPS20/RPS6	6
R-HSA-72766	Translation	10/39	291/10704	5.98015997026291e-08	5.44071914143676e-07	3.57012329171517e-07	PABPC1/RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	10
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	6/39	59/10704	6.12375314620588e-08	5.44071914143676e-07	3.57012329171517e-07	PABPC1/RPS12/RPS17/RPS18/RPS20/RPS6	6
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	5/39	51/10704	1.02331824910689e-06	8.75505613124782e-06	5.74494455638955e-06	RPS12/RPS17/RPS18/RPS20/RPS6	5
R-HSA-72702	Ribosomal scanning and start codon recognition	5/39	58/10704	1.95938669471548e-06	1.61649402314027e-05	1.06072061668808e-05	RPS12/RPS17/RPS18/RPS20/RPS6	5
R-HSA-71291	Metabolism of amino acids and derivatives	9/39	374/10704	5.89485726729004e-06	4.6955587198069e-05	3.08115951538935e-05	RPL30/RPL32/RPL41/RPLP0/RPS12/RPS17/RPS18/RPS20/RPS6	9
R-HSA-1236977	Endosomal/Vacuolar pathway	3/39	11/10704	7.23174115303793e-06	5.5684406878392e-05	3.65393237206127e-05	B2M/HLA-A/HLA-B	3
R-HSA-6803157	Antimicrobial peptides	5/39	95/10704	2.24605194125725e-05	0.000167367096267879	0.000109823931932443	CHGA/PLA2G2A/PRSS2/REG3A/REG3G	5
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	3/39	25/10704	9.73077952212387e-05	0.000702440646753317	0.000460931661574288	B2M/HLA-A/HLA-B	3
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	2/39	10/10704	0.000571476116991807	0.00400033281894265	0.00262496206847911	B2M/HLA-A	2
R-HSA-6798695	Neutrophil degranulation	7/39	480/10704	0.00153986017812062	0.0104619912101725	0.00686501132041392	ANPEP/B2M/HLA-A/HLA-B/HSP90AB1/PIGR/PRSS2	7
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	2/39	21/10704	0.00260023651772902	0.0171615610170115	0.0112611746933227	B2M/HLA-A	2
R-HSA-1236974	ER-Phagosome pathway	3/39	83/10704	0.00335989128351029	0.0215593024025244	0.0141469106674118	B2M/HLA-A/HLA-B	3
R-HSA-877300	Interferon gamma signaling	3/39	91/10704	0.00435429920184208	0.02718494907096	0.0178383807984426	B2M/HLA-A/HLA-B	3
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	2/39	28/10704	0.0046057938983982	0.0279983786981575	0.0183721418661867	B2M/HLA-A	2
R-HSA-1236975	Antigen processing-Cross presentation	3/39	98/10704	0.00535677805903261	0.0317286085035009	0.0208198661403697	B2M/HLA-A/HLA-B	3
R-HSA-977225	Amyloid fiber formation	3/39	110/10704	0.00737642317105232	0.0425988438128271	0.0279527614903035	B2M/H2AC19/H4C15	3
R-HSA-2172127	DAP12 interactions	2/39	45/10704	0.0116022021865733	0.0639775830549281	0.0419811891542932	B2M/HLA-B	2
R-HSA-6809371	Formation of the cornified envelope	3/39	130/10704	0.0116322878281687	0.0639775830549281	0.0419811891542932	KRT19/KRT20/KRT8	3
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	3/39	132/10704	0.0121211916072685	0.0651161688669539	0.0427283131321092	B2M/HLA-A/HLA-B	3
R-HSA-171306	Packaging Of Telomere Ends	2/39	52/10704	0.0152934691861394	0.0802907132272319	0.0526856354737817	H2AC19/H4C15	2
R-HSA-9018519	Estrogen-dependent gene expression	3/39	150/10704	0.0170541551719186	0.084701622318154	0.0555800119107504	H2AC19/H4C15/HSP90AB1	3
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	2/39	56/10704	0.017600337105071	0.084701622318154	0.0555800119107504	H2AC19/H4C15	2
R-HSA-110331	Cleavage of the damaged purine	2/39	56/10704	0.017600337105071	0.084701622318154	0.0555800119107504	H2AC19/H4C15	2
R-HSA-73927	Depurination	2/39	56/10704	0.017600337105071	0.084701622318154	0.0555800119107504	H2AC19/H4C15	2
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	2/39	61/10704	0.0206777736978823	0.0936581514551141	0.0614571602166162	H2AC19/H4C15	2
R-HSA-110329	Cleavage of the damaged pyrimidine 	2/39	61/10704	0.0206777736978823	0.0936581514551141	0.0614571602166162	H2AC19/H4C15	2
R-HSA-73928	Depyrimidination	2/39	61/10704	0.0206777736978823	0.0936581514551141	0.0614571602166162	H2AC19/H4C15	2
R-HSA-73728	RNA Polymerase I Promoter Opening	2/39	63/10704	0.0219673426730558	0.0957444558014319	0.0628261637521357	H2AC19/H4C15	2
R-HSA-73929	Base-Excision Repair, AP Site Formation	2/39	63/10704	0.0219673426730558	0.0957444558014319	0.0628261637521357	H2AC19/H4C15	2
R-HSA-5334118	DNA methylation	2/39	65/10704	0.0232896059309359	0.0996277587045592	0.0653743324377148	H2AC19/H4C15	2
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	2/39	67/10704	0.0246440456092709	0.102666009882459	0.0673679900800827	H2AC19/H4C15	2
R-HSA-427359	SIRT1 negatively regulates rRNA expression	2/39	68/10704	0.0253331712696978	0.102666009882459	0.0673679900800827	H2AC19/H4C15	2
R-HSA-9670095	Inhibition of DNA recombination at telomere	2/39	68/10704	0.0253331712696978	0.102666009882459	0.0673679900800827	H2AC19/H4C15	2
R-HSA-909733	Interferon alpha/beta signaling	2/39	70/10704	0.0267349165272722	0.106478719272412	0.0698698362963193	HLA-A/HLA-B	2
R-HSA-212300	PRC2 methylates histones and DNA	2/39	73/10704	0.0288953262197801	0.110397973006169	0.0724415954107464	H2AC19/H4C15	2
R-HSA-2299718	Condensation of Prophase Chromosomes	2/39	74/10704	0.0296306247895345	0.110397973006169	0.0724415954107464	H2AC19/H4C15	2
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	2/39	74/10704	0.0296306247895345	0.110397973006169	0.0724415954107464	H2AC19/H4C15	2
R-HSA-774815	Nucleosome assembly	2/39	74/10704	0.0296306247895345	0.110397973006169	0.0724415954107464	H2AC19/H4C15	2
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	2/39	76/10704	0.0311235951912995	0.114119849034765	0.0748838380542544	H2AC19/H4C15	2
R-HSA-1221632	Meiotic synapsis	2/39	79/10704	0.033418070634217	0.118762681792371	0.0779303995356639	H2AC19/H4C15	2
R-HSA-3214858	RMTs methylate histone arginines	2/39	79/10704	0.033418070634217	0.118762681792371	0.0779303995356639	H2AC19/H4C15	2
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	2/39	80/10704	0.0341973264597694	0.119690642609193	0.078539314357365	H2AC19/H4C15	2
R-HSA-913531	Interferon Signaling	3/39	199/10704	0.0354403153554609	0.121812406187914	0.0799315857418985	B2M/HLA-A/HLA-B	3
R-HSA-1462054	Alpha-defensins	1/39	10/10704	0.0358581974925462	0.121812406187914	0.0799315857418985	PRSS2	1
R-HSA-912446	Meiotic recombination	2/39	86/10704	0.0390202284848943	0.129468287025485	0.084955266947687	H2AC19/H4C15	2
R-HSA-2980736	Peptide hormone metabolism	2/39	90/10704	0.0423715743187814	0.129468287025485	0.084955266947687	ANPEP/GIP	2
R-HSA-9616222	Transcriptional regulation of granulopoiesis	2/39	90/10704	0.0423715743187814	0.129468287025485	0.084955266947687	H2AC19/H4C15	2
R-HSA-6805567	Keratinization	3/39	214/10704	0.0425157828426755	0.129468287025485	0.084955266947687	KRT19/KRT20/KRT8	3
R-HSA-3371511	HSF1 activation	1/39	12/10704	0.0428779688626604	0.129468287025485	0.084955266947687	HSP90AB1	1
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	2/39	91/10704	0.0432258951079261	0.129468287025485	0.084955266947687	H2AC19/H4C15	2
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	2/39	91/10704	0.0432258951079261	0.129468287025485	0.084955266947687	H2AC19/H4C15	2
R-HSA-73772	RNA Polymerase I Promoter Escape	2/39	91/10704	0.0432258951079261	0.129468287025485	0.084955266947687	H2AC19/H4C15	2
R-HSA-73884	Base Excision Repair	2/39	92/10704	0.0440866968464706	0.129468287025485	0.084955266947687	H2AC19/H4C15	2
R-HSA-1912408	Pre-NOTCH Transcription and Translation	2/39	93/10704	0.0449539236759668	0.129468287025485	0.084955266947687	H2AC19/H4C15	2
R-HSA-3214815	HDACs deacetylate histones	2/39	94/10704	0.0458275200403259	0.129468287025485	0.084955266947687	H2AC19/H4C15	2
R-HSA-2168880	Scavenging of heme from plasma	1/39	13/10704	0.0463691547225894	0.129468287025485	0.084955266947687	JCHAIN	1
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	1/39	13/10704	0.0463691547225894	0.129468287025485	0.084955266947687	GIP	1
R-HSA-75205	Dissolution of Fibrin Clot	1/39	13/10704	0.0463691547225894	0.129468287025485	0.084955266947687	S100A10	1
R-HSA-5625740	RHO GTPases activate PKNs	2/39	95/10704	0.046707430684448	0.129468287025485	0.084955266947687	H2AC19/H4C15	2
R-HSA-8939211	ESR-mediated signaling	3/39	223/10704	0.0470793771001765	0.129468287025485	0.084955266947687	H2AC19/H4C15/HSP90AB1	3
R-HSA-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	2/39	97/10704	0.0484859752883497	0.131767768136574	0.0864641540745803	H2AC19/H4C15	2
R-HSA-189483	Heme degradation	1/39	14/10704	0.0498479315410175	0.132354852712357	0.086849390706673	FABP1	1
R-HSA-3371568	Attenuation phase	1/39	14/10704	0.0498479315410175	0.132354852712357	0.086849390706673	HSP90AB1	1
R-HSA-844456	The NLRP3 inflammasome	1/39	15/10704	0.0533143422678556	0.139950148453121	0.0918333168250144	HSP90AB1	1
R-HSA-399954	Sema3A PAK dependent Axon repulsion	1/39	16/10704	0.0567684297083606	0.144153352954463	0.0945914004349176	HSP90AB1	1
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	2/39	106/10704	0.0567876844972127	0.144153352954463	0.0945914004349176	H2AC19/H4C15	2
R-HSA-5578749	Transcriptional regulation by small RNAs	2/39	106/10704	0.0567876844972127	0.144153352954463	0.0945914004349176	H2AC19/H4C15	2
R-HSA-427413	NoRC negatively regulates rRNA expression	2/39	107/10704	0.0577391643154151	0.144975510400662	0.0951308885745969	H2AC19/H4C15	2
R-HSA-1912422	Pre-NOTCH Expression and Processing	2/39	109/10704	0.0596589409909121	0.14555242582529	0.09550945235289	H2AC19/H4C15	2
R-HSA-1482922	Acyl chain remodelling of PI	1/39	17/10704	0.0602102365236091	0.14555242582529	0.09550945235289	PLA2G2A	1
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	2/39	110/10704	0.0606271357653539	0.14555242582529	0.09550945235289	H2AC19/H4C15	2
R-HSA-73854	RNA Polymerase I Promoter Clearance	2/39	110/10704	0.0606271357653539	0.14555242582529	0.09550945235289	H2AC19/H4C15	2
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	2/39	112/10704	0.0625798850810687	0.14555242582529	0.09550945235289	H2AC19/H4C15	2
R-HSA-73864	RNA Polymerase I Transcription	2/39	112/10704	0.0625798850810687	0.14555242582529	0.09550945235289	H2AC19/H4C15	2
R-HSA-157579	Telomere Maintenance	2/39	113/10704	0.0635643392145841	0.14555242582529	0.09550945235289	H2AC19/H4C15	2
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	1/39	18/10704	0.0636398052309708	0.14555242582529	0.09550945235289	ANPEP	1
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	1/39	18/10704	0.0636398052309708	0.14555242582529	0.09550945235289	GAST	1
R-HSA-9610379	HCMV Late Events	2/39	116/10704	0.0665494228673047	0.150390370536486	0.0986840435509411	H2AC19/H4C15	2
R-HSA-1482925	Acyl chain remodelling of PG	1/39	19/10704	0.0670571782045805	0.150390370536486	0.0986840435509411	PLA2G2A	1
R-HSA-1500620	Meiosis	2/39	118/10704	0.0685654212786307	0.152294349186189	0.0999334075316076	H2AC19/H4C15	2
R-HSA-622312	Inflammasomes	1/39	20/10704	0.0704623976758041	0.154634771275484	0.101469159551924	HSP90AB1	1
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	2/39	121/10704	0.0716273615864797	0.154634771275484	0.101469159551924	H2AC19/H4C15	2
R-HSA-5619507	Activation of HOX genes during differentiation	2/39	121/10704	0.0716273615864797	0.154634771275484	0.101469159551924	H2AC19/H4C15	2
R-HSA-2559580	Oxidative Stress Induced Senescence	2/39	125/10704	0.0757787690853885	0.161627966872398	0.106057996033836	H2AC19/H4C15	2
R-HSA-8935690	Digestion	1/39	22/10704	0.0772365443255252	0.161627966872398	0.106057996033836	LIPF	1
R-HSA-9613829	Chaperone Mediated Autophagy	1/39	22/10704	0.0772365443255252	0.161627966872398	0.106057996033836	HSP90AB1	1
R-HSA-1482801	Acyl chain remodelling of PS	1/39	23/10704	0.0806055552571212	0.161627966872398	0.106057996033836	PLA2G2A	1
R-HSA-400508	Incretin synthesis, secretion, and inactivation	1/39	23/10704	0.0806055552571212	0.161627966872398	0.106057996033836	GIP	1
R-HSA-162909	Host Interactions of HIV factors	2/39	130/10704	0.0810744173185776	0.161627966872398	0.106057996033836	B2M/HLA-A	2
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	2/39	130/10704	0.0810744173185776	0.161627966872398	0.106057996033836	H2AC19/H4C15	2
R-HSA-163560	Triglyceride catabolism	1/39	24/10704	0.0839625801934537	0.161627966872398	0.106057996033836	FABP1	1
R-HSA-166208	mTORC1-mediated signalling	1/39	24/10704	0.0839625801934537	0.161627966872398	0.106057996033836	RPS6	1
R-HSA-3371571	HSF1-dependent transactivation	1/39	24/10704	0.0839625801934537	0.161627966872398	0.106057996033836	HSP90AB1	1
R-HSA-429947	Deadenylation of mRNA	1/39	24/10704	0.0839625801934537	0.161627966872398	0.106057996033836	PABPC1	1
R-HSA-9660826	Purinergic signaling in leishmaniasis infection	1/39	24/10704	0.0839625801934537	0.161627966872398	0.106057996033836	HSP90AB1	1
R-HSA-9664424	Cell recruitment (pro-inflammatory response)	1/39	24/10704	0.0839625801934537	0.161627966872398	0.106057996033836	HSP90AB1	1
R-HSA-9609690	HCMV Early Events	2/39	135/10704	0.0864829394484861	0.165103793492564	0.10833878452007	H2AC19/H4C15	2
R-HSA-211000	Gene Silencing by RNA	2/39	136/10704	0.0875776961482133	0.165823342706863	0.108810942582767	H2AC19/H4C15	2
R-HSA-189445	Metabolism of porphyrins	1/39	26/10704	0.0906408380384094	0.167939042997122	0.110199235322787	FABP1	1
R-HSA-6803529	FGFR2 alternative splicing	1/39	26/10704	0.0906408380384094	0.167939042997122	0.110199235322787	PTBP1	1
R-HSA-73886	Chromosome Maintenance	2/39	141/10704	0.0931143330705553	0.167939042997122	0.110199235322787	H2AC19/H4C15	2
R-HSA-8963743	Digestion and absorption	1/39	27/10704	0.0939621535765727	0.167939042997122	0.110199235322787	LIPF	1
R-HSA-9635486	Infection with Mycobacterium tuberculosis	1/39	27/10704	0.0939621535765727	0.167939042997122	0.110199235322787	B2M	1
R-HSA-3214847	HATs acetylate histones	2/39	142/10704	0.0942339298441734	0.167939042997122	0.110199235322787	H2AC19/H4C15	2
R-HSA-68875	Mitotic Prophase	2/39	142/10704	0.0942339298441734	0.167939042997122	0.110199235322787	H2AC19/H4C15	2
R-HSA-9006931	Signaling by Nuclear Receptors	3/39	299/10704	0.0945111497386403	0.167939042997122	0.110199235322787	H2AC19/H4C15/HSP90AB1	3
R-HSA-1474165	Reproduction	2/39	143/10704	0.0953575171174378	0.168149514917009	0.110337344033034	H2AC19/H4C15	2
R-HSA-1482788	Acyl chain remodelling of PC	1/39	28/10704	0.097271648379468	0.170225384664069	0.111699500531447	PLA2G2A	1
R-HSA-5683826	Surfactant metabolism	1/39	29/10704	0.100569363414425	0.174673104877686	0.114618031908803	DMBT1	1
R-HSA-212165	Epigenetic regulation of gene expression	2/39	149/10704	0.102180501826131	0.176146984491315	0.115585170958074	H2AC19/H4C15	2
R-HSA-1482839	Acyl chain remodelling of PE	1/39	30/10704	0.103855339510616	0.17640134872759	0.115752081188303	PLA2G2A	1
R-HSA-2424491	DAP12 signaling	1/39	30/10704	0.103855339510616	0.17640134872759	0.115752081188303	B2M	1
R-HSA-5339562	Uptake and actions of bacterial toxins	1/39	31/10704	0.107129617359509	0.180634610292311	0.118529887819972	HSP90AB1	1
R-HSA-1592389	Activation of Matrix Metalloproteinases	1/39	33/10704	0.113643240395465	0.188860349146421	0.123927501832238	PRSS2	1
R-HSA-420092	Glucagon-type ligand receptors	1/39	33/10704	0.113643240395465	0.188860349146421	0.123927501832238	GIP	1
R-HSA-9609646	HCMV Infection	2/39	160/10704	0.115029192529354	0.189798167673434	0.124542885144564	H2AC19/H4C15	2
R-HSA-5689901	Metalloprotease DUBs	1/39	37/10704	0.126531882744669	0.205837076859286	0.135067391513954	H2AC19	1
R-HSA-8979227	Triglyceride metabolism	1/39	37/10704	0.126531882744669	0.205837076859286	0.135067391513954	FABP1	1
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	1/39	38/10704	0.129725400750946	0.209556416597682	0.137507969879545	RPLP0	1
R-HSA-1483166	Synthesis of PA	1/39	40/10704	0.136078343378788	0.218292342503473	0.143240361451356	PLA2G2A	1
R-HSA-165159	MTOR signalling	1/39	41/10704	0.139237846811668	0.221820293886174	0.145555353472814	RPS6	1
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	1/39	42/10704	0.14238609064308	0.225282102318845	0.147826943421799	JCHAIN	1
R-HSA-983169	Class I MHC mediated antigen processing & presentation	3/39	370/10704	0.15104281419102	0.237352993728746	0.155747692398904	B2M/HLA-A/HLA-B	3
R-HSA-9020591	Interleukin-12 signaling	1/39	47/10704	0.157959778753471	0.246545330351701	0.161779574256755	RPLP0	1
R-HSA-69275	G2/M Transition	2/39	196/10704	0.159592102627787	0.247421313469925	0.162354382044517	HSP90AB1/MZT2B	2
R-HSA-2559583	Cellular Senescence	2/39	197/10704	0.160874610301481	0.24774689986428	0.162568027252022	H2AC19/H4C15	2
R-HSA-453274	Mitotic G2-G2/M phases	2/39	198/10704	0.162159122037429	0.248071239673153	0.162780854467687	HSP90AB1/MZT2B	2
R-HSA-1461973	Defensins	1/39	50/10704	0.167171356902604	0.252395970225501	0.165618681761094	PRSS2	1
R-HSA-3214842	HDMs demethylate histones	1/39	50/10704	0.167171356902604	0.252395970225501	0.165618681761094	H4C15	1
R-HSA-191859	snRNP Assembly	1/39	53/10704	0.17628472042425	0.262721099470979	0.172393886187382	PHAX	1
R-HSA-194441	Metabolism of non-coding RNA	1/39	53/10704	0.17628472042425	0.262721099470979	0.172393886187382	PHAX	1
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	1/39	55/10704	0.182306236503979	0.268234016767	0.176011384891538	HSP90AB1	1
R-HSA-429914	Deadenylation-dependent mRNA decay	1/39	55/10704	0.182306236503979	0.268234016767	0.176011384891538	PABPC1	1
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1/39	56/10704	0.185300889220322	0.269210725848393	0.176652287638043	HSP90AB1	1
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	1/39	56/10704	0.185300889220322	0.269210725848393	0.176652287638043	PABPC1	1
R-HSA-447115	Interleukin-12 family signaling	1/39	57/10704	0.188284854783847	0.271836259094179	0.178375125584697	RPLP0	1
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	1/39	59/10704	0.194220872884997	0.276961750274058	0.181738400726655	HLA-A	1
R-HSA-68886	M Phase	3/39	418/10704	0.194232915776612	0.276961750274058	0.181738400726655	H2AC19/H4C15/MZT2B	3
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	1/39	61/10704	0.200114586419134	0.281868716236708	0.184958282698045	HSP90AB1	1
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1/39	61/10704	0.200114586419134	0.281868716236708	0.184958282698045	RPS6	1
R-HSA-201681	TCF dependent signaling in response to WNT	2/39	233/10704	0.208154797153957	0.289777122438111	0.190147667491857	H2AC19/H4C15	2
R-HSA-1442490	Collagen degradation	1/39	64/10704	0.208876477398383	0.289777122438111	0.190147667491857	PRSS2	1
R-HSA-162906	HIV Infection	2/39	234/10704	0.209492551719327	0.289777122438111	0.190147667491857	B2M/HLA-A	2
R-HSA-373755	Semaphorin interactions	1/39	65/10704	0.211776272265062	0.290008905723369	0.190299760419982	HSP90AB1	1
R-HSA-157118	Signaling by NOTCH	2/39	236/10704	0.21217101760714	0.290008905723369	0.190299760419982	H2AC19/H4C15	2
R-HSA-8878171	Transcriptional regulation by RUNX1	2/39	239/10704	0.216195747891574	0.293771869193845	0.192768964064314	H2AC19/H4C15	2
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	1/39	69/10704	0.223272237525705	0.301613373499636	0.197914448776248	H4C15	1
